AMPK As A Target in Rare Diseases.

Area of Science:

• Biochemistry
• Cell Biology
• Genetics

Background:

• AMP-activated protein kinase (AMPK) is a key regulator of cellular energy homeostasis across eukaryotes.
• AMPK influences critical cellular processes including fatty acid oxidation, glucose transport, and mitochondrial biogenesis.
• Dysregulation of AMPK signaling is implicated in various systemic diseases and rare pathologies.

Purpose of the Study:

• To review the pathophysiological roles of AMPK in rare diseases.
• To explore the therapeutic potential of targeting AMPK in rare disease contexts.
• To consolidate current knowledge on AMPK's involvement in debilitating conditions.

Main Methods:

• Literature review of scientific articles focusing on AMPK and rare diseases.
• Analysis of studies investigating AMPK alterations in specific rare pathologies.
• Examination of research on pharmacological modulation of AMPK activity for therapeutic benefit.

Main Results:

• AMPK plays a significant role in the pathogenesis of numerous rare diseases, including mitochondrial disorders, muscular dystrophies, cardiovascular diseases, and neurodegenerative conditions.
• Alterations in AMPK signaling have been observed in several rare diseases.
• Treatments targeting AMPK activity have shown promise in preclinical studies for certain rare conditions.

Conclusions:

• AMPK is a critical factor in the development and progression of many rare diseases.
• Targeting AMPK represents a promising therapeutic avenue for rare diseases lacking effective treatments.
• Further research into AMPK's role and therapeutic targeting is warranted for rare disease management.